Description:
An enabling excipient used in oral dosage forms.

Text:
This results in fast dissolution where the subsequent 
maintenance of supersaturated drug concentrations in vivo can drive absorption from the 
gastrointestinal tract.13 Oral dosage forms comprising ASDs have been successfully marketed, 
e.g. Venclexta, which is used to treat diseases such as chronic lymphocytic leukemia, and acute 
myeloid leukemia, and contains venetoclax as the active pharmaceutical ingredient and polyvinyl 
alcohol as the enabling excipient.
